INTRODUCTION
============

Despite continuing advances in surgical techniques, several complications in the biliary duct may occur after biliary surgery. Benign biliary strictures (BBSs) develop in 15%--20% of patients undergoing orthotopic liver transplantation (OLT) and in 19%--40% of those undergoing living-donor liver transplantation (LDLT) \[[@b1-ce-2020-095]\]. They also occur in 0.4%--0.6% of patients undergoing laparoscopic cholecystectomy \[[@b2-ce-2020-095]\]. The cause of BBSs after liver transplantation may include hypertrophic changes and ischemia due to intraoperative damage to the blood vessels supplying the bile duct. These strictures are difficult to manage because of the acutely angulated and tortuous bile duct at the anastomotic site \[[@b3-ce-2020-095]-[@b6-ce-2020-095]\]. Although BBSs are the most common complication after biliary surgery, no standardized treatment has been established for their management \[[@b7-ce-2020-095]-[@b10-ce-2020-095]\].

In the initial years of biliary operation, most bile duct complications were treated surgically. However, surgical treatment has high rates of morbidity and mortality, and cannot be recommended for patients with inflammation in the bile duct \[[@b11-ce-2020-095]\]. With the development of percutaneous transhepatic biliary drainage (PTBD) as an interventional radiologic procedure, recanalization of BBSs using an interventional technique has become possible. Insertion of multiple plastic stents (MPSs) or metal stents with or without balloon dilation through endoscopic retrograde cholangiopancreatography (ERCP) has also shown good results in the treatment of BBSs \[[@b5-ce-2020-095]\]. Recanalization of BBSs is possible with a high resolution rate owing to advances in nonsurgical methods such as endoscopic and percutaneous techniques. Therefore, nonsurgical treatment of BBSs after biliary surgery is safer and more effective than surgical treatment \[[@b9-ce-2020-095],[@b12-ce-2020-095]\].

However, endoscopic or percutaneous treatment cannot be successful when it is impossible to place a guidewire percutaneously or endoscopically through the BBS owing to complete obstruction and severe stricture in the bile duct. In these cases, patients should have an external PTBD catheter to drain bile, which places a major burden on the patient by lowering the quality of life and conferring a high risk of infection.

Magnetic compression anastomosis (MCA) has been applied as a nonsurgical technique for reconstructing a refractory or completely obstructing BBS that cannot be resolved with conventional methods \[[@b13-ce-2020-095]-[@b24-ce-2020-095]\]. MCA is a method of recanalizing the obstructed bile duct by inserting magnets at both ends of the stenosis, inducing necrosis of the stenotic lesion through the pulling force of magnets. In this review, the principle and clinical results of MCA will be discussed with respect to two types of strictures: biliobiliary strictures and bilioenteric strictures.

INDICATIONS FOR MCA
===================

The development of endoscopic and percutaneous treatments has enabled the resolution of BBSs \[[@b25-ce-2020-095]-[@b29-ce-2020-095]\]. However, nonsurgical treatments cannot resolve severely narrowed or completely occluded bile ducts in which passage of a guidewire or dye is impossible. Accordingly, the indications for MCA are severe stenosis or complete obstruction of the bile duct that cannot be treated with usual endoscopic or percutaneous methods ([Fig. 1](#f1-ce-2020-095){ref-type="fig"}) \[[@b11-ce-2020-095],[@b18-ce-2020-095],[@b21-ce-2020-095]-[@b23-ce-2020-095],[@b30-ce-2020-095]-[@b32-ce-2020-095]\].

PRE-ASSESSMENT FOR SUCCESSFUL MCA
=================================

Pre-MCA assessment is needed to plan the approximation of magnets and to predict outcomes. Factors affecting the success of MCA include the length of the stricture, shape of the bile duct, power of the magnets, and axis of the bile duct. MCA may fail when the stricture is long and the bile duct is tapered or twisted in shape \[[@b22-ce-2020-095],[@b23-ce-2020-095]\]. The longer the stricture, the weaker the magnetic power between the two magnets. If the magnetic force is too weak, tissue necrosis due to magnetic compression cannot occur and a new fistula does not form. Therefore, exact evaluation of the length of the stricture is essential for a successful approximation of magnets before MCA. However, radiologic studies (computed tomography, ultrasonography, and magnetic resonance cholangiopancreatography) cannot exactly assess the length of a stricture. Cholangiographic assessment of biliary ducts using ERCP or PTBD may be feasible; however, they are invasive procedures.

Evaluating the axis and shape of the bile duct is also substantial for the success of MCA. Even if the stricture is relatively short, the magnet cannot fully reach the stricture if the bile duct is tapered and rotated. In tapered and rotated bile ducts, MCA can fail because the true distance between the two magnets will be longer than the measured stricture \[[@b22-ce-2020-095]\]. Moreover, the axis of the bile ducts is important because it determines the direction of alignment of the two magnets. If the magnets are aligned parallel, MCA fails owing to weak magnetic power \[[@b22-ce-2020-095],[@b23-ce-2020-095]\]. Noninvasive radiologic tools have a limitation in identifying suitable MCA candidates because they cannot accurately evaluate the stricture length and shape, as well as the axis of the bile duct, for a successful MCA. Therefore, preassessments for MCA has limitations and the success of MCA could only be actually predicted while performing the procedure until now.

MCA PROCEDURE
=============

The process of MCA is divided into four steps ([Fig. 2](#f2-ce-2020-095){ref-type="fig"}): formation of the tract for magnet delivery, approximation of magnets, removal of the approximated magnets, and maintenance and removal of the internal catheter \[[@b22-ce-2020-095],[@b24-ce-2020-095]\]. The common routes of magnet delivery are percutaneous and peroral. The percutaneous tract for the delivery of magnets is formed using the PTBD tract. The PTBD tract is sequentially dilated to 16 Fr, and the PTBD catheter is changed to an 18 Fr sheath in the process of MCA approximation. This process allows the insertion of magnets without difficulties and duct injury through the sheath during the movement of the magnets. The peroral route for magnet approximation is performed using ERCP. A retrieval fully covered self-expandable metal stent (FCSEMS) is inserted into the common bile duct (CBD) to deliver the magnet via the oral route after an endoscopic sphincterotomy.

A silk thread attached to one magnet is fixed to a polypectomy snare, and the magnet is moved to the stricture site through the PTBD tract. Another polypectomy snare is passed through the channel of an ERCP scope, and the other magnet is fixed in front of the scope. The magnet is moved to the anastomosis site through the FCSEMS. This process is performed under controlled aseptic conditions with the same level of infection control as for the operating room, and no MCA procedure- related infection has been reported.

After one magnet is moved to the stricture via the 18-Fr sheath, the other magnet is applied to the stricture site through an FCSEMS in the CBD. After the placement of the two magnets, the magnets are approximated through their attraction to each other. The distance between the two magnets is made shorter by pushing them using a balloon catheter through the PTBD and ERCP tracts. Radiologic cholangiography is performed to confirm the approximation of the two magnets. After confirming the approximation, the 18-Fr sheath is replaced with an indwelling 16-Fr PTBD catheter and the FCSEMS placed in the CBD is removed.

After the approximation, the two magnets compress the stricture tissue, leading to ischemic necrosis of the stricture tissue. As the magnets gradually become closer to each other, the ischemic necrosis process accelerates and a new fistula is finally formed. The magnets after full approximation can spontaneously migrate into the CBD or enteric tract through the new fistula. A plain abdominal radiograph is obtained at 2-week intervals for 6--8 weeks after the successful approximation of magnets to confirm the migration of the magnets through the fistula tract. If the magnets remain in the stricture site with close approximation after 10 weeks, they can be removed using percutaneous transhepatic cholangioscopy (PTCS). The mean duration for a successful magnet removal after magnet approximation was reported to be 53.3 days (range, 9--181 days) for biliobiliary strictures and 7--40 days for bilioenteric strictures \[[@b33-ce-2020-095],[@b34-ce-2020-095]\]. The factors for successful magnet removal include the distance between the two magnets, the magnetic power of the two magnets, and the histologic characteristics of the stricture site.

Recanalized fistula is confirmed endoscopically under fluoroscopy after magnet removal. The mean indwelling duration of the PTCS catheter or an FCSEMS to maintain the new fistula tract is 4--6 months. The PTCS catheter and FCSEMS have exhibited similar safety and efficacy for fistula maintenance \[[@b35-ce-2020-095]\]. However, the FCSEMS is more convenient for patients because the PTCS catheter has a longer indwelling duration and requires more number of replacements.

RESULTS OF MCA IN BILIOBILIARY STRICTURES
=========================================

Post-living-donor liver transplantation strictures
--------------------------------------------------

BBSs are a relatively common complication of liver transplantation. Extensive stripping of the blood vessels during the operation can cause ischemic injury \[[@b4-ce-2020-095]\] and hypertrophic change \[[@b3-ce-2020-095]\] promotes biliobiliary anastomotic strictures \[[@b5-ce-2020-095]\]. Although the optimal strategy for BBSs has not been determined, nonsurgical approaches are more popular. The insertion of MPSs with or without balloon dilatation is currently the treatment of choice \[[@b36-ce-2020-095]\]. The success rate of MPSs is approximately 70%--91% in patients with BBSs after deceased-donor liver transplantation and 60%--100% in those with BBSs after LDLT \[[@b36-ce-2020-095]-[@b39-ce-2020-095]\]. FCSEMS has a similar stricture resolution rate to MPS, but the number of ERCP sessions is fewer \[[@b1-ce-2020-095],[@b40-ce-2020-095]\]. However, MPS and FCSEMS insertion cannot be applied when a guidewire cannot pass though the stricture.

The overall clinical success rate of MCA for biliobiliary strictures was reported to be 87.5%, and the recurrence rate was 7.1% ([Table 1](#t1-ce-2020-095){ref-type="table"}). The clinical success rates of MCA differ according to the etiology of the stricture and the treatment method in biliobiliary strictures \[[@b41-ce-2020-095]-[@b45-ce-2020-095]\]. Although surgery-related strictures and strictures due to stones have high resolution rates with endoscopic treatment, idiopathic and chronic pancreatitis-related strictures respond poorly to endoscopic management \[[@b46-ce-2020-095]\]. The clinical success rate of endoscopic treatment for biliobiliary strictures is 90% in postoperative strictures but only 65% in strictures due to chronic pancreatitis \[[@b46-ce-2020-095]\]. Moreover, the resolution rates of percutaneous treatment of biliobiliary strictures were reported to be from 61.4% to 90.9%.47-50 Although advances in conventional techniques have increased the clinical success rates, these methods are unsuccessful for severe stenotic strictures through which passage of a guidewire is impossible. Therefore, these methods cannot be used to resolve all biliobiliary strictures. Moreover, with conventional methods, the clinical resolution rates are lower than the technical success rates, because of stricture recurrence. Repeated pneumatic dilation can cause traumatic tissue injury and promote a fibrotic reaction resulting in the recurrence of strictures \[[@b51-ce-2020-095]\].

The early complication rates after MCA are not reported in most studies ([Table 1](#t1-ce-2020-095){ref-type="table"}). The main adverse event is mild cholangitis, which can be resolved with conservative treatment \[[@b22-ce-2020-095],[@b23-ce-2020-095]\]. The only reported adverse event occurring from magnet approximation to the removal of the indwelling catheter is a slight fever \[[@b34-ce-2020-095]\]. Doppler ultrasound is performed to evaluate the vessel because the risk of vessel rupture is a concern during the early stages of MCA \[[@b17-ce-2020-095],[@b19-ce-2020-095]\]. However, no blood vessel rupture has been reported to date. As the magnets gradually get closer to each other during a long period after magnet approximation, the intervening vessels are not compressed or ruptured. The mean duration of full magnet approximation is 53.3 days in biliobiliary strictures and 7--40 days in bilioenteric strictures \[[@b23-ce-2020-095]\].

No late adverse events and MCA procedure-related mortality have been reported during the follow-up. Adverse events related to magnets have not been reported because the magnets are aseptic devices that do not induce an inflammatory or immune reaction in the bile duct. Moreover, no adverse events directly related to other equipment used in MCA have been reported because the MCA procedure is performed using conventional ERCP techniques and a PTBD tract. Therefore, the MCA procedure seems to be safe in patients undergoing liver transplantation or with an immunocompromised status.

The length of the stricture is an important consideration for a successful MCA. The strictures are usually longer and the shape is more tortuous in LDLT recipients than in OLT recipients. Moreover, the distance between the approximated magnets is shorter for bilioenteric anastomoses (2--7 mm) than for biliobiliary anastomoses (2--15 mm). The technical factors influencing the effectiveness of MCA are stricture length, duration from LDLT to stricture occurrence, shape of the bile duct, and magnetic power of the magnets. The maximal stricture length for a successful MCA has not been confirmed and needs to be evaluated.

MCA creates a new fistula tract through tissue necrosis instead of simple dilation of fibrotic tissue in BBSs; thus, the recurrence rate seems to be lower than that with other conventional treatments. The possibility of elastic recoiling in the fistula formed by MCA may be lower. Moreover, a PTBD catheter is not needed and the risk of infection is low after recanalization with MCA. However, the long-term efficacy of MCA should be clarified by further large-scale and long-term follow-up studies.

As MCA is applied in biliary strictures that could not be resolved using conventional methods, it is difficult to compare its advantages and disadvantages with those of conventional methods, and it cannot replace conventional methods. Currently, MCA is not widely used because the magnets and equipment used in MCA are not commercially available, and cases that are indicated for MCA are relatively rare.

Post-orthotopic liver transplantation strictures
------------------------------------------------

BBSs are more frequent after LDLT than after OLT \[[@b52-ce-2020-095]-[@b56-ce-2020-095]\]. Overall, the incidence of BBSs is 25%--32% after LDLT \[[@b57-ce-2020-095]-[@b61-ce-2020-095]\] and 5%--15% after OLT \[[@b39-ce-2020-095],[@b60-ce-2020-095],[@b62-ce-2020-095]\]. The higher incidence of post-LDLT strictures is due to technical aspects of the operation because ductal anastomosis between the donor and the recipient during LDLT is complicated. Moreover, the duct of the donor liver has many variants, including multiple bile ducts, a poor blood supplement, and a relatively short stump for the anastomosis \[[@b9-ce-2020-095],[@b60-ce-2020-095],[@b61-ce-2020-095],[@b63-ce-2020-095]\].

The MCA process in post-OLT strictures is the same as in post-LDLT strictures ([Fig. 3](#f3-ce-2020-095){ref-type="fig"}). The level of post-OLT strictures is more distal in the CBD than that of post-LDLT strictures. Post-OLT strictures are mid-level BBSs but post-LDLT strictures are high-level BBSs. In addition, intrahepatic ducts (IHDs) are more dilated but less angulated and tortuous in post-OLT strictures than in post-LDLT strictures. Therefore, MCA is more feasible and the success rate is high in post-OLT strictures ([Fig. 3](#f3-ce-2020-095){ref-type="fig"}).

Post-cholecystectomy strictures
-------------------------------

Bile duct injury during laparoscopic cholecystectomy has occurred with an incidence of 0.3%--0.6% \[[@b64-ce-2020-095]\]. The type of biliary injuries can be categorized according to the Bismuth \[[@b65-ce-2020-095]\], Strasberg \[[@b66-ce-2020-095]\], and Stewart-Way classifications \[[@b67-ce-2020-095]\]. The Stewart-Way classification categorizes biliary injuries into four types according to the mechanism and anatomy \[[@b67-ce-2020-095]\]. Stewart-Way class I injuries are immediately resolved during the operation. Stewart-Way class II injuries with stricture are managed with insertion of MPSs and FCSEMS. Stewart-Way class III and IV injuries can be treated using multidisciplinary methods \[[@b68-ce-2020-095]\]. A combined endoscopic-radiologic rendezvous technique is needed for complete transection of the main bile duct (Stewart-Way class III) and transection of a sectoral bile duct (Stewart-Way class IV). This technique can avoid surgical reintervention, and can reduce surgical morbidity and mortality. These endoscopic-radiologic rendezvous techniques for treating bile duct stenosis or complete obstruction are feasible only if the guidewire can pass through the stricture. MCA can be an alternative method for patients with Stewart-Way class III and IV ductal injuries that cannot be resolved using rendezvous techniques ([Fig. 4](#f4-ce-2020-095){ref-type="fig"}). The procedure for MCA is similar to the procedures applied in patients with post-LDLT strictures.

Other biliary strictures after surgery
--------------------------------------

Bile duct injury and stricture may also occur after other hepatobiliary operations including hepatectomy. Complex dissection, poorly defined anatomy, or management of intraoperative bleeding by clipping can cause early-phase stricture \[[@b69-ce-2020-095]\]. Late-phase stricture may result from ischemic injury in the bile ducts, and a stricture may not develop clinically until several years after the initial injury. Endoscopic treatment with MPS or FCSEMS insertion is a more preferred method for strictures after biliary surgery than percutaneous treatment, but multidisciplinary approaches involving endoscopists, radiologists, and surgeons are usually required to resolve these complicated BBSs. Usually, an endoscopic or percutaneous approach can be useful if the guidewire can pass through the BBS. However, MCA can be applied when these conventional methods cannot resolve the BBS. The technique for MCA in this situation is also similar to that used for post-LDLT strictures.

MCA FOR BILIOENTERIC STRICTURES
===============================

Hepaticojejunostomy site strictures
-----------------------------------

BBSs are caused by postoperative complications, especially after a Roux-en-Y reconstruction, which is the most common method of anastomosis in biliary surgery ([Table 2](#t2-ce-2020-095){ref-type="table"}). The mean distance between the approximated magnets was reported to be 4 mm (range, 2--7 mm), and the duration from magnet approximation to magnet removal was 7--40 days. Complete resolution of the obstruction was accomplished in 41 of 42 patients (97.6%), and no severe complications were observed. The recurrence rate was low (follow-up period: mean, 40 months; range, 2--53 months). One patient had restenosis at 6 days after the removal of the indwelling catheter, which was treated successfully and without difficulty with balloon dilation \[[@b34-ce-2020-095]\].

The difference in the MCA method between bilioenteric anastomosis strictures and biliobilary strictures is the route for magnet delivery \[[@b24-ce-2020-095],[@b34-ce-2020-095],[@b70-ce-2020-095]\]. The delivery route for magnets in biliobiliary strictures is mainly the percutaneous-peroral tract. However, the delivery routes for magnets in bilioenteric strictures are various and include the percutaneous-peroral tract, surgically formed percutaneous-enteric tract, or percutaneous- percutaneous tract. The method of magnet delivery to the percutaneous tract is similar to that described previously. With the peroral approach, a forward-viewing endoscope is used instead of an ERCP scope \[[@b23-ce-2020-095]\]. A peroral approach with the forward-viewing endoscope is sometimes difficult in patients with long and redundant afferent loops. Single-balloon enteroscopy is feasible in these situations \[[@b71-ce-2020-095]\]. If the endoscope cannot approach the stricture site, magnets can be delivered through a surgically formed percutaneous-enteric fistula \[[@b23-ce-2020-095]\]. When the left and right IHDs are anastomosed separately to the jejunum and the stricture occurs in the right IHD, two PTCS scopes can be applied for MCA \[[@b72-ce-2020-095]\]. One magnet is moved through the right IHD using one PTCS scope, and the other through the left IHD to approximate via the left IHD tract using another PTCS scope. The cases described above provide the possible methods of magnet delivery that can be applied in various situations.

CONCLUSIONS
===========

MCA is a nonsurgical alternative for treating severe or completely obstructing BBSs that cannot be resolved using conventional endoscopic or percutaneous methods. MCA is safe and feasible in the management of biliobiliary and bilioenteric strictures occurring after various operations. Although an effective and reliable pre-MCA assessment method has not yet been established, modification of magnets and development of effective magnet delivery systems have increased the success rate of MCA. The understanding of the mechanisms and principles of MCA by endoscopists can expand the clinical indications of MCA and enable further applications and developments of this method.
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![Cholangiogram showing indications for magnetic compression anastomosis (MCA). MCA can be applied for a refractory benign biliary stricture that could not be resolved using conventional endoscopic or percutaneous methods because of complete obstruction through which neither (A) a guidewire nor (B) dye is able to pass.](ce-2020-095f1){#f1-ce-2020-095}

![Magnetic compression anastomosis for a stricture after living-donor liver transplantation. (A) A percutaneous transhepatic biliary drainage (PTBD) catheter was inserted and dilated to 16 Fr. (B) One magnet was delivered through the PTBD tract, and the other magnet was moved using an endoscopic retrograde cholangiopancreatography scope through the common bile duct. The approximation of magnets was successful and the PTBD catheter was inserted. (C) The approximated magnets were removed using percutaneous transhepatic cholangioscopy via the PTBD tract. (D) The cholangiogram showed a recanalized tract after magnet removal. (E) A retrievable, fully covered self-expandable metal stent (FCSEMS) was inserted for 6 months (exchanging every 3 months). (F) Finally, formation of a new fistula was confirmed after the removal of the indwelling FCSEMS.](ce-2020-095f2){#f2-ce-2020-095}

![Magnetic compression anastomosis for a stricture after orthotopic donor liver transplantation. (A) A percutaneous transhepatic biliary drainage (PTBD) catheter was inserted and dilated to 16 Fr. (B) One magnet was delivered through the PTBD tract, and the other magnet was moved using an endoscopic retrograde cholangiopancreatography (ERCP) scope through the common bile duct. The approximation of magnets was successful and the PTBD catheter was inserted. (C) The approximated magnets were removed using percutaneous transhepatic cholangioscopy via the PTBD tract and ERCP scope. The bottom right color photograph shows the approximated magnets. (D) Cholangiogram showing the recanalized tract after magnet removal. (E) A retrievable, fully covered self-expandable metal stent was inserted for 6 months (exchanging every 3 months). (F) The recanalized fistula was formed widely, compared with the cholangiogram in (D).](ce-2020-095f3){#f3-ce-2020-095}

![Magnetic compression anastomosis for a post-cholecystectomy stricture. (A) Common hepatic duct stricture that occurred after laparoscopic cholecystectomy. (B) One magnet was moved through the percutaneous transhepatic biliary drainage (PTBD) tract, and a second magnet was delivered via the common bile duct using a duodenoscope. Magnet approximation was successful but the distance between two magnets was long. However, the two magnets moved closer to each other because of magnetic power, and magnet approximation was successful. (C) The approximated magnets were removed using percutaneous transhepatic cholangioscopy via the PTBD tract and endoscopic retrograde cholangiopancreatography scope. (D) Cholangiogram showing the recanalized tract after magnet removal. (E) A retrievable, fully covered self-expandable metal stent (FCSEMS) was inserted for 6 months (exchanging every 3 months). (F) Finally, formation of a new fistula was confirmed after the removal of the indwelling FCSEMS. The bottom right color photograph shows the removed FCSEMS.](ce-2020-095f4){#f4-ce-2020-095}

###### 

Results of Magnetic Compression Anastomosis in Biliobiliary Strictures

  Study                                          Type of article            Age (yr)/Sex                                                          Reason for surgery                                                       Previous surgery                                 Distance between magnets (mm)   Anastomosis
  ---------------------------------------------- -------------------------- --------------------------------------------------------------------- ------------------------------------------------------------------------ ------------------------------------------------ ------------------------------- -------------
  Mimuro et al. (2003) \[[@b17-ce-2020-095]\]    Case report                76/F                                                                  Pancreatic cancer                                                        DP                                               12                              Partial
  Itoi et al. (2005) \[[@b18-ce-2020-095]\]      Case report                76/F                                                                  Bile duct cancer                                                         None                                             8                               Partial
  Okajima et al. (2005) \[[@b30-ce-2020-095]\]   Case report                44/F                                                                  Fulminant hepatitis                                                      LDLT                                             2                               Complete
  Akita et al. (2008) \[[@b41-ce-2020-095]\]     Case report                34/F                                                                  N/A                                                                      LDLT                                             2                               Complete
  Matsuno et al. (2009) \[[@b14-ce-2020-095]\]   Case report                53/M                                                                  N/A                                                                      LDLT                                             2                               Complete
  Itoi et al. (2010) \[[@b33-ce-2020-095]\]      Case report                60/M                                                                  N/A                                                                      LDLT                                             N/A                             Complete
  Itoi et al. (2011) \[[@b71-ce-2020-095]\]      Case report                40/F                                                                  Liver metastasis from colon cancer                                       Right three segmental + S3 partial hepatectomy   15                              Complete
  Jang et al. (2011) \[[@b22-ce-2020-095]\]      Retrospective study        Mean, 53.8/M:F = 9:3                                                  LC (3), HCC (7), HF (2)                                                  LDLT                                             N/A                             Complete
  Oya et al. (2012) \[[@b31-ce-2020-095]\]       Case report                24/M                                                                  N/A                                                                      LDLT                                             N/A                             Partial
  Jang et al. (2014) \[[@b23-ce-2020-095]\]      Case report (2 patients)   45/M                                                                  Abdominal trauma                                                         Embolization                                     4                               Complete
  38/F                                           Cholecystitis              Cholecystitis                                                         6                                                                        Complete                                                                         
  Ersoz et al. (2016) \[[@b42-ce-2020-095]\]     Case report (6 patients)   Mean, 54.8/M:F = 4:2                                                  LC                                                                       LDLT                                             5--15                           Complete
  Jang et al. (2017) \[[@b24-ce-2020-095]\]      Retrospective study        Mean, 53.4/M:F = 31:8^[a)](#tfn1-ce-2020-095){ref-type="table-fn"}^   LC (18), HCC (8), HF (3)^[b)](#tfn2-ce-2020-095){ref-type="table-fn"}^   LDLT                                             N/A                             Complete
  Parlak et al. (2017) \[[@b43-ce-2020-095]\]    Retrospective study        Mean, 55.7/M:F = 6:3                                                  LC                                                                       LDLT (7)                                         2.5--6                          Complete
  OLT (2)                                                                                                                                                                                                                                                                                                   
  Jiang et al. (2018) \[[@b44-ce-2020-095]\]     Case report                64/F                                                                  Liver metastasis from rectal cancer                                      Right partial hepatectomy                        N/A                             Complete
  Li et al. (2020) \[[@b45-ce-2020-095]\]        Retrospective study        Mean, 49/M:F = 7:2                                                    LC                                                                       OLT                                              2--7                            Complete

DP, dorsal pancreatectomy; HCC, dorsal pancreatectomy; HF, hepatic failure; LC, liver cirrhosis; LDLT, living-donor liver transplantation; N/A, not available; OLT, orthotopic liver transplantation.

These age and sex data represent all 39 patients in the study, 35 of whom had biliobiliary strictures (which occurred after LDLT in 29 patients).

These numbers represent 29 patients with post-LDLT biliobiliary strictures.

###### 

Results of Magnetic Compression Anastomosis in Bilioenteric Strictures

  Study                                           Type of article            Age (yr)/Sex                 Reason for operation                                Previous operation                                Distance between magnets (mm)   Anastomosis
  ----------------------------------------------- -------------------------- ---------------------------- --------------------------------------------------- ------------------------------------------------- ------------------------------- --------------------------
  Takao et al. (2001) \[[@b21-ce-2020-095]\]      Case report                70/M                         Gastric cancer                                      Subtotal gastrectomy (B-II)                       2                               Complete
  Muraoka et al. (2005) \[[@b19-ce-2020-095]\]    Case report (2 cases)      1/F                          Fulminant hepatitis                                 LDLT (left lobe) with R-Y                         2                               Complete
  57/M                                            LC + HCC                   LDLT (right lobe) with R-Y   5                                                   Complete                                                                          
  Yukawa et al. (2008) \[[@b20-ce-2020-095]\]     Case report                83/M                         Gastric and gallbladder cancer                      Distal gastrectomy with R-Y and cholecystectomy   N/A                             Complete
  Avaliani et al. (2009) \[[@b11-ce-2020-095]\]   Retrospective study        Mean, 64/M:F = 9:25          Cancer of VA (7), pancreatic cancer (21), CCC (6)   None                                              N/A                             Complete (except 1 case)
  Suyama et al. (2010) \[[@b32-ce-2020-095]\]     Case report                78/M                         Gallbladder cancer                                  Radical cholecystectomy with R-Y                  N/A                             Complete
  Itoi et al. (2011) \[[@b71-ce-2020-095]\]       Case report                60/F                         CCC                                                 Expanded left lobectomy with R-Y                  2                               Complete
  Jang et al. (2014) \[[@b23-ce-2020-095]\]       Case series (3 patients)   49/M                         Pancreatic NET                                      PPPD with HJstomy                                 5                               Complete
  27/M                                            Choledochal cyst           Excision of cyst with R-Y    5                                                   Complete                                                                          
  63/F                                            Pancreatic NET             Whipple operation with R-Y   77                                                  Complete                                                                          
  Liu et al. (2019) \[[@b70-ce-2020-095]\]        Case report (4 patients)   Median, 69/M:F = 3:1         Peri-ampullary carcinoma                            PPPD                                              N/A                             Complete

B-II, Billroth II; CCC, cholangiocellular carcinoma; HCC, hepatocellular carcinoma; HJstomy, hepaticojejunostomy; LC, liver cirrhosis; LDLT, living-donor liver transplantation; N/A, not available; NET, neuroendocrine tumor; PPPD, pylorus-preserving pancreaticoduodenectomy; R-Y, Roux-en-Y anastomosis; VA, Vater's ampulla.
